<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>04987780861037</udiDi>
    <basicUdiDi>4987780detectionAWT</basicUdiDi>
    <tradeName>N-Histofine Simple Stain MAX PO (M)</tradeName>
    <deviceName>N-Histofine Simple Stain MAX PO</deviceName>
    <manufacturerName>Nichirei Biosciences Inc.</manufacturerName>
    <manufacturerSrn>JP-MF-000027151</manufacturerSrn>
    <authorisedRepresentativeName>MedEnvoy Global BV</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000024028</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>434131F</reference>
    <placedOnMarketCountry>Czechia</placedOnMarketCountry>
    <lastUpdated>2026-07-31T04:43:36.799Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108712961</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108712961</tradeName>
    <deviceName>Secondary Antisera</deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABC008</reference>
    <placedOnMarketCountry>Netherlands</placedOnMarketCountry>
    <lastUpdated>2026-07-16T00:53:30.988Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108712978</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108712978</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABC015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.195Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108712985</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108712985</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABC125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.164Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108712992</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108712992</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABC500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.129Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713012</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713012</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABE008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.075Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713029</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713029</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABE015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713036</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713036</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABE125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:57.009Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713043</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713043</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABE500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.988Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713050</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713050</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABF008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.965Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713067</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713067</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABF015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.939Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713074</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713074</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABF125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.914Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713081</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713081</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABF500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.897Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713197</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713197</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABJ008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.680Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713203</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713203</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABJ015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.658Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713210</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713210</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABJ125</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.635Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713227</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713227</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABJ500</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.611Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713234</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713234</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABJ999</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.586Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713241</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713241</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABK008</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.562Z</lastUpdated>
  </row>
  <row>
    <udiDi>00810108713258</udiDi>
    <basicUdiDi>081010871W01030710F3</basicUdiDi>
    <tradeName>00810108713258</tradeName>
    <deviceName></deviceName>
    <manufacturerName>ScyTek Laboratories Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000023816</manufacturerSrn>
    <authorisedRepresentativeName>Emergo Europe B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000000116</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf A</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W01030710</emdnCode>
    <emdnDescription>SECONDARY ANTISERA FOR IMMUNOHISTOLOGY</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>ABK015</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-08T06:52:56.538Z</lastUpdated>
  </row>
</eudamedExport>